The Impact of Maternal Obesity on the Duration of Labor Stages in Dinoprostone-Induced Vaginal Delivery
- PMID: 40364240
- PMCID: PMC12072416
- DOI: 10.3390/jcm14093209
The Impact of Maternal Obesity on the Duration of Labor Stages in Dinoprostone-Induced Vaginal Delivery
Abstract
Objective: Dinoprostone vaginal inserts are widely used as one of the primary pharmacological methods for labor induction. In this study, we aimed to investigate whether BMI affects the duration of the different phases of labor in pregnant women undergoing vaginal delivery induced with slow-release dinoprostone. Methods: A prospective study was conducted on pregnant women at a tertiary maternity hospital between August 2021 and February 2023. Patients were categorized into three groups according to BMI: normal-weight, overweight, and obese. The duration of total labor and each phase of induced labor was recorded. Multivariate analysis was used to determine the association between maternal obesity and the duration of each phase of the labor process. Results: The final analysis included 205 women who received slow-release dinoprostone for labor induction. The mean maternal age was significantly lower in the normal-weight group (p < 0.01). The obese group showed a higher need for oxytocin augmentation and had a higher median infant birth weight compared to the normal and overweight groups. After adjusting for confounders, multivariate linear regression analysis showed that the duration of the latent phase of labor did not differ between the groups. However, the duration of the active phase of labor and total induced labor were significantly longer in the obese group. Conclusions: An increased BMI in pregnant women is associated with a longer active phase and overall labor duration during dinoprostone-induced delivery.
Keywords: body mass index; dinoprostone; labor duration; labor induction; vaginal delivery.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Effect of obesity on labor duration among nulliparous women with epidural analgesia.J Matern Fetal Neonatal Med. 2020 Jul;33(13):2195-2201. doi: 10.1080/14767058.2018.1543655. Epub 2019 Jan 4. J Matern Fetal Neonatal Med. 2020. PMID: 30394154
-
Results of the RE-DINO multicenter randomized trial on the repeated use of vaginal dinoprostone (Propess®) for labor induction in patients at term.Am J Obstet Gynecol MFM. 2024 Nov;6(11):101510. doi: 10.1016/j.ajogmf.2024.101510. Epub 2024 Sep 27. Am J Obstet Gynecol MFM. 2024. PMID: 39343101 Clinical Trial.
-
Maternal body mass index and duration of labor.Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):49-53. doi: 10.1016/j.ejogrb.2013.08.021. Epub 2013 Aug 29. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 24041847
-
Prediction of the induction to delivery time interval in vaginal dinoprostone-induced labor: a retrospective study in a Chinese tertiary maternity hospital.J Int Med Res. 2019 Jun;47(6):2647-2654. doi: 10.1177/0300060519845780. Epub 2019 May 17. J Int Med Res. 2019. PMID: 31096809 Free PMC article.
-
Vaginal delivery among women who underwent labor induction with vaginal dinoprostone (PGE2) insert: a retrospective study of 1656 women in China.J Matern Fetal Neonatal Med. 2019 May;32(10):1721-1727. doi: 10.1080/14767058.2017.1416351. Epub 2017 Dec 21. J Matern Fetal Neonatal Med. 2019. PMID: 29268652
References
-
- Keirse M.J. Prostaglandins in preinduction cervical ripening. Meta-analysis of world-wide clinical experience. J. Reprod. Med. 1993;38((Suppl. S1)):69–98. - PubMed
LinkOut - more resources
Full Text Sources